An optimal dose-finding technique based on bayesian decision theory for oncology phase I/II clinical trials
A phase I dose-finding clinical trial has always been a challenge to find a safe dosage, given a very limited sample size and shorter timeframe. This is particularly important for cancer trials as new experimental drugs could be cytotoxic and life threatening if too high a dose is given or an inaccu...
Saved in:
Main Author: | Loke, Yee Chong |
---|---|
Other Authors: | Cai Yiyu |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/41746 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Decision-theoretic designs for dose-finding clinical trials with multiple outcomes
by: Fan, S.K., et al.
Published: (2014) -
Design of phase I and II clinical trials in oncology and ethical issues involved
by: Goh, B.C.
Published: (2016) -
A Bayesian Decision Approach for Sample Size Determination in Phase II Trials
by: LEUNG, Denis H. Y., et al.
Published: (2001) -
Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: A phase II, multicenter, randomized, dose-finding clinical trial
by: Neena Valecha, et al.
Published: (2018) -
A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell's viper antivenom in Myanmar
by: James A. Watson, et al.
Published: (2020)